Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paresh Vyas

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Blood|December 6, 2014
Targeting HIF function: the debate continuesParesh Vyas
Cancer Discovery|March 3, 2021
Poorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic GroupsParesh Vyas
Blood|November 9, 2023
Changing treatment changing prognosis of mutationsParesh Vyas
Disease Models & Mechanisms|December 23, 2020
Disease Models & Mechanisms announces a new Editor-in-ChiefParesh Vyas
Cell Stem Cell|February 5, 2022
Genetic and non-genetic mechanisms of inflammation may promote transformation in leukemiaParesh Vyas
Science (New York, N.Y.)|July 10, 2021
Sowing the seeds of leukemia before birthIrene Roberts, Paresh Vyas
Frontiers in Oncology|December 6, 2019
The Graft-Versus-Leukemia Effect in AMLConnor Sweeney, Paresh Vyas
Advances in Enzyme Regulation|July 22, 2006
Characterization of the hemopoietic defect in early stages of the myelodysplastic syndromesParesh Vyas, Alexander Sternberg
Immunity|July 18, 2019
The Inflammasome: More Than a Protective Innate Immune MechanismBilyana Stoilova, Paresh Vyas
Blood|December 24, 2011
Enigmatic variationIrene Roberts, Paresh Vyas
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Blood|December 6, 2014
Targeting HIF function: the debate continuesParesh Vyas
Cancer Discovery|March 3, 2021
Poorer Clinical Outcomes for Black Patients with AML: A Wake-Up Call for Better Data and Greater Understanding of Cancer Outcomes in All Ethnic GroupsParesh Vyas
Blood|November 9, 2023
Changing treatment changing prognosis of mutationsParesh Vyas
Disease Models & Mechanisms|December 23, 2020
Disease Models & Mechanisms announces a new Editor-in-ChiefParesh Vyas
Cell Stem Cell|February 5, 2022
Genetic and non-genetic mechanisms of inflammation may promote transformation in leukemiaParesh Vyas
Science (New York, N.Y.)|July 10, 2021
Sowing the seeds of leukemia before birthIrene Roberts, Paresh Vyas
Frontiers in Oncology|December 6, 2019
The Graft-Versus-Leukemia Effect in AMLConnor Sweeney, Paresh Vyas
Advances in Enzyme Regulation|July 22, 2006
Characterization of the hemopoietic defect in early stages of the myelodysplastic syndromesParesh Vyas, Alexander Sternberg
Immunity|July 18, 2019
The Inflammasome: More Than a Protective Innate Immune MechanismBilyana Stoilova, Paresh Vyas
Blood|December 24, 2011
Enigmatic variationIrene Roberts, Paresh Vyas
Pageof 21